A type 1 diagnosis in a child usually arrives at speed and out of nowhere — a few weeks of more thirst than usual, more visits to the toilet than usual, a child who's gone slightly thin, and then a phone call from the GP or a trip to A&E and the world rearranges. The first 48 hours are a flood of new equipment, new vocabulary, and the slow realisation that this isn't going away.
The honest reassurance for the days afterwards: this is a chronic condition that families learn to live around. The technology now does substantially more of the work than it did even five years ago, the diabetes team will become a fixture, and most children with well-managed type 1 grow up to do everything any other child does. The first month is brutal. The first year is hard. And then a different kind of normal sets in.
Healthbooq (healthbooq.com/apps/healthbooq-kids) covers endocrine and chronic conditions in children. For a broader overview, see the complete guide to child health.
What's Actually Happening
Type 1 diabetes is autoimmune. The immune system, for reasons that aren't fully understood, attacks and destroys the beta cells in the pancreas — the cells that make insulin. Genetic susceptibility (certain HLA types) plus environmental triggers (likely viral) seem to set the process off, but no parent did anything to cause it. It is not caused by diet, weight, or anything you fed your child as a baby.
Without insulin, glucose can't get into cells where it's needed. So glucose builds up in the blood (which is why it's spilled into the urine, dragging water with it — hence the thirst and constant peeing) while the body switches to burning fat and protein for fuel. That switch produces ketones. When ketones rise high enough, the blood becomes acidic — diabetic ketoacidosis (DKA). DKA is what makes a child suddenly very unwell, often before the diagnosis has been made.
Spotting It Early — the Four Ts
Diabetes UK's campaign distils the picture into four signs:
- Toilet — going more often, sometimes a previously dry child wetting the bed again
- Thirsty — drinking far more than usual, often during the night
- Tired — flatter, less interested, sleeping more
- Thinner — unexplained weight loss, despite eating normally or more
Recurrent thrush, fruity-smelling breath, and tummy aches are also common. Any combination — particularly thirst plus weight loss — should mean a finger-prick glucose test that day. A glucose over 11.1 mmol/L in a symptomatic child confirms the diagnosis.
The reason early recognition matters: catching it before DKA develops means the diagnosis is made in clinic, not in a resus bay. UK rates of DKA at first diagnosis remain stubbornly above 20%, and the campaign exists to bring that number down.
DKA — the Emergency Picture
A child with type 1 diabetes (newly diagnosed or established) who develops:
- Persistent vomiting
- Deep, fast breathing (Kussmaul respiration)
- Abdominal pain
- Fruity, acetone-smelling breath
- Drowsiness or confusion
— is in DKA until proven otherwise. Call 999. Don't wait for the GP.
For a child already known to have type 1, the warning combination is high glucose plus ketones plus feeling unwell. The team's helpline number should be on the fridge. Sick day rules — never stop background insulin, give correction doses, check ketones, hydrate — are taught to every family early on.
Insulin: How It's Given
There are two main approaches in the UK:
Multiple daily injections (MDI). A long-acting background insulin (degludec, glargine) once or twice a day to cover the steady demand, plus a rapid-acting insulin (aspart, lispro, glulisine) injected before each meal or carb-containing snack. Doses are calculated using a carbohydrate-to-insulin ratio (e.g. 1 unit per 10g carbohydrate) and a correction factor for high readings. This is the standard starting regimen for most newly diagnosed children.
Insulin pump (CSII — continuous subcutaneous insulin infusion). A small device worn on the body delivering rapid-acting insulin continuously through a thin cannula, with the user telling it to deliver a meal bolus when eating. NICE (TA151) recommends pump therapy for under-12s where MDI isn't working well, and it's also widely offered to older children and teenagers.
Both regimens require carb counting, which is taught early — the dietitian becomes one of the most useful members of the team.
Continuous Glucose Monitoring (CGM)
A small sensor on the arm or abdomen reading glucose every minute or two, sending data to a phone, reader, or pump. The Libre and Dexcom systems are the main UK options.
NHS England funds CGM for every child with type 1 diabetes. This represents a real improvement over the previous era — fewer finger-pricks, real-time trend data, alarms that wake parents before a hypo becomes dangerous. The classic JDRF CGM Study Group trials (NEJM, 2008 and onward) established that CGM lowers HbA1c without raising hypoglycaemia.
A few practicalities families pick up over time:
- Sensors stay on for around 7–14 days depending on device.
- A finger-prick is still useful when symptoms don't match the CGM reading or the trend arrow looks suspicious.
- The "share" function lets parents see the child's glucose remotely — a school day saver, but use sparingly with teenagers.
Hybrid Closed-Loop ("Artificial Pancreas") Systems
A CGM, an insulin pump, and an algorithm running on a phone or pump that automatically adjusts background insulin in response to readings. The user still doses for meals, but the system handles the gaps overnight and between meals.
In the UK, CamAPS FX, developed by Roman Hovorka's group at Cambridge, was the first widely available hybrid closed-loop system, and NHS commissioning has expanded considerably from 2024 — meaning many more children are eligible. Other systems (Tandem Control-IQ, Medtronic 780G, Omnipod 5) are increasingly available too.
The trial data is consistent: closed-loop improves time-in-range, reduces hypoglycaemia, and reduces the cognitive load on family and child. Worth asking the team about if you haven't yet.
Hypoglycaemia — Recognising and Treating
A blood glucose under 4 mmol/L is a hypo. Children's typical symptoms include:
- Shaking, sweating, pale skin
- Hunger
- Behavioural change — irritability, tearfulness, sudden fatigue
- Confusion, blurred vision in worse hypos
- Younger children sometimes can't articulate what they feel and just go quiet or ratty
The standard treatment is 15 g of fast-acting carbohydrate:
- 4–5 glucose tablets, or
- 150 ml of fizzy non-diet drink (Lucozade, original Coca-Cola), or
- 200 ml fruit juice, or
- A small tube of glucose gel
Recheck in 15 minutes; repeat if still under 4. Once back up, follow with a longer-acting snack (a piece of toast, a couple of biscuits) if no meal is due.
Severe hypo — unconscious or fitting — is treated with glucagon: GlucaGen (intramuscular injection) or Baqsimi (nasal spray). Both raise glucose within minutes and can be given by trained adults at home or school. Every child should have glucagon available at home and at school, with trained staff at school who know how to use it. Then call 999.
Daily Life and School
The Children and Families Act 2014 places a legal duty on schools to support children with medical conditions. Every child with type 1 should have an Individual Healthcare Plan (IHP) — drafted between the diabetes team, the family, and the school — covering:
- Where insulin and snacks are kept
- Who supervises lunchtime dosing
- The plan for hypos
- Glucagon training and storage
- PE, school trips, exams
Sports lower glucose during and for hours afterwards. The standard plan is to check before activity, reduce the pre-activity insulin if needed, have fast-acting carb on hand, and check glucose for several hours after — the late hypo at 3am after a Saturday football match is a known pattern.
Birthday parties, sleepovers, school trips, holidays — all manageable, all need a bit of planning. The team will help build the playbook over the first year.
What Long-Term Care Looks Like
The DCCT trial (NEJM, 1993) and its long follow-up (EDIC) established the durable principle: tighter glycaemic control reduces long-term complications — retinopathy, kidney disease, neuropathy. The UK target HbA1c for children is below 48 mmol/mol (6.5%), balanced against avoiding severe hypos and protecting quality of life.
Annual review covers:
- HbA1c
- Blood pressure and lipids
- Thyroid function — autoimmune thyroid disease occurs in 17–30% of children with type 1
- Coeliac screening (anti-tTG) — coeliac coexists in 5–10%
- Urine microalbumin from age 12 or 5 years after diagnosis — early kidney signal
- Eye screening from age 12
Adolescence
Will be its own challenge. Hormones drive insulin requirements up unpredictably; social pressures collide with visible diabetes management; the handover from parent-led to teenager-led care is the central task of these years. Diabulimia — restricting insulin to lose weight — is a serious eating-disorder pattern unique to type 1 and needs alerting to early. The team will keep a particularly close eye in these years; it's not a sign things are going wrong, it's because everyone's experience says they are harder.
When to Call the Team
Most parents want to know which questions are worth a phone call. The shortlist:
- Persistent high readings despite correction doses
- Ketones positive on testing, even if glucose isn't very high
- Vomiting illness — sick day rules need active support
- Severe hypo with glucagon used — even after the child seems fine
- New medication being prescribed by another doctor (steroids especially)
- Anxiety or low mood in the child or family that's getting in the way of care
The team would rather hear from you than not.
Key Takeaways
Type 1 diabetes affects around 1 in 500 UK children. The diagnosis usually arrives after a few weeks of thirst, peeing constantly, weight loss, and exhaustion — Diabetes UK calls them the Four Ts. The picture every parent needs to know is DKA: vomiting, deep fast breathing, abdominal pain, and a sweet smell on the breath, which means hospital that day. Modern care has changed in a real way over the last decade — continuous glucose monitors are funded for every child with type 1, and hybrid closed-loop systems (CamAPS FX and others) automatically adjust insulin from the CGM, easing the constant cognitive load. The target is HbA1c below 48 mmol/mol (6.5%) while keeping quality of life and avoiding severe hypos.
